Functional characterization of the 26RFa/orexin neurons of the lateral hypothalamic area reveals their key role in the control of glucose homeostasis

The study delves into the function and molecular mechanisms of a specific subset of lateral hypothalamic area neurons that produce anti-hyperglycemic neuropeptides, 26RFa and orexin. By employing a range of techniques including chemogenetic, pharmacological, and genetic methods, researchers investigated the role of these neurons in maintaining glucose homeostasis.

The team discovered that these lateral hypothalamic 26RFa neurons also express orexin, forming a unique peptidergic population that shares similar anti-hyperglycemic functions. Surprisingly, activating these neurons chemogenetically led to increased glucose levels, contradicting the expected glucose-lowering effects of the co-secreted neuropeptides.

Delving deeper, the researchers analyzed the gene expression patterns in response to neuronal activation. They observed that this activation induced a coordinated reduction in the expression of both 26RFa and orexin, counteracting their intended anti-hyperglycemic actions. Genetic experiments revealed that orexin signaling played a more significant role in mediating the metabolic effects of the activated neurons, while 26RFa signaling was crucial for dynamically regulating orexin expression.

The findings offer fresh insights into the functional organization of lateral hypothalamic area 26RFa/orexin neurons and shed light on how coordinated signaling by these neuropeptides contributes to systemic glucose homeostasis.